ConductScience.org, home

Paper36958586

Silver nitroprusside as an efficient chemodynamic therapeutic agent and a peroxynitrite nanogenerator for targeted cancer therapies.

Asif K and 7 others. J Adv Res, 2024. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Silver nitroprusside as an efficient chemodynamic therapeutic agent and a peroxynitrite nanogenerator for targeted cancer therapies. Papers, record 36958586. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36958586

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Silver nitroprusside as an efficient chemodynamic therapeutic agent and a peroxynitrite nanogenerator for targeted cancer therapies.
PubMed
Journal
J Adv Res
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
3.17, provisional
iCite
Revised in PubMed
2024-12-09
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Asif KKanwal
2Adeel MMuhammad
3Rahman MMMd Mahbubur
4Sfriso AAAndrea Augusto
5Bartoletti MMichele
6Canzonieri VVincenzo
7Rizzolio FFlavio
8Caligiuri IIsabella

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SilverMajor topic
NeoplasmsMajor topic
Mice
Animals
Humans
Reactive Oxygen Species
Nitroprusside
Peroxynitrous Acid
Hydrogen Peroxide

Source PubMed

Download CSV of topics

References71

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111701324Ten years of protein kinase B signalling: a hard Akt to follow.Trends Biochem Sci2001https://conductscience.org/library/papers/11701324PubMed
235211255Recent advances of cancer chemodynamic therapy based on Fenton/Fenton-like chemistry.Chem Sci2022https://conductscience.org/library/papers/35211255PubMed
322809647Mechanisms of the pH dependent generation of hydroxyl radicals and oxygen induced by Ag nanoparticles.Biomaterials2012https://conductscience.org/library/papers/22809647PubMed
420175529Ion release kinetics and particle persistence in aqueous nano-silver colloids.Environ Sci Technol2010https://conductscience.org/library/papers/20175529PubMed
533036656High-throughput approaches for precision medicine in high-grade serous ovarian cancer.J Hematol Oncol2020https://conductscience.org/library/papers/33036656PubMed
619698986Antiangiogenic properties of silver nanoparticles.Biomaterials2009https://conductscience.org/library/papers/19698986PubMed
725569205N-Pyridineium-2-yl Darrow Red analogue: unique near-infrared lysosome-biomarker for the detection of cancer cells.Anal Chem2015https://conductscience.org/library/papers/25569205PubMed
827960409An Intelligent and Tumor-Responsive Fe2+ Donor and Fe2+-Dependent Drugs Cotransport System.ACS Appl Mater Interfaces2016https://conductscience.org/library/papers/27960409PubMed
921468968Annexin V/7-AAD staining in keratinocytes.Methods Mol Biol2011https://conductscience.org/library/papers/21468968PubMed
109403032Modulation of NF-kappa B, and Bcl-2 in apoptosis induced by cisplatin in HeLa cells.Mutat Res1997https://conductscience.org/library/papers/9403032PubMed
1118359055The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth.Water Res2008https://conductscience.org/library/papers/18359055PubMed
1228109747Silver nanoparticles induce hormesis in A549 human epithelial cells.Toxicol In Vitro2017https://conductscience.org/library/papers/28109747PubMed
1320380484Three-dimensional culture of hepatocytes for prediction of drug-induced hepatotoxicity.Expert Opin Drug Metab Toxicol2010https://conductscience.org/library/papers/20380484PubMed
1430048028Chemodynamic Therapy: Tumour Microenvironment-Mediated Fenton and Fenton-like Reactions.Angew Chem Int Ed Engl2019https://conductscience.org/library/papers/30048028PubMed
1527180073Differential genotoxicity mechanisms of silver nanoparticles and silver ions.Arch Toxicol2017https://conductscience.org/library/papers/27180073PubMed
1616968214Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.Annu Rev Pharmacol Toxicol2007https://conductscience.org/library/papers/16968214PubMed
1723876760Anti-leukemia activity of PVP-coated silver nanoparticles via generation of reactive oxygen species and release of silver ions.Biomaterials2013https://conductscience.org/library/papers/23876760PubMed
1828063851Fluorescent real-time quantitative measurements of intracellular peroxynitrite generation and inhibition.Anal Biochem2017https://conductscience.org/library/papers/28063851PubMed
1933168016Elucidating the cellular response of silver nanoparticles as a potential combinatorial agent for cisplatin chemotherapy.J Nanobiotechnology2020https://conductscience.org/library/papers/33168016PubMed
2035582641Fenton metal nanomedicines for imaging-guided combinatorial chemodynamic therapy against cancer.Asian J Pharm Sci2022https://conductscience.org/library/papers/35582641PubMed

See all 71 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
41754782Silver Nanoparticles as Anticancer Agents: Mechanisms Insight, Current Studies, and Limitations.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41754782PubMed
41149286Characterization of M11-like and OC125-like Monoclonal Antibody Binding to CA125 Tandem Repeats.Biosensors (Basel)2025https://conductscience.org/library/papers/41149286PubMed
40611788Multi-Functional Polydopamine-Mucin Hollow Particles Provide Tunable Shell Permeability, ROS Scavenging, Tissue Adhesion, and Lubricity for Biomedical Applications.Small2025https://conductscience.org/library/papers/40611788PubMed
39303357Exploration of organoids in ovarian cancer: From basic research to clinical translation.Transl Oncol2024https://conductscience.org/library/papers/39303357PubMed
39175687Biodegradation of hydroxylated boron nitride nanoplatelets, their toxic effect and drug delivery application.RSC Adv2024https://conductscience.org/library/papers/39175687PubMed
39092168Targeted therapy in high grade serous ovarian Cancer: A literature review.Gynecol Oncol Rep2024https://conductscience.org/library/papers/39092168PubMed
38063781Nanoenabled Intracellular Metal Ion Homeostasis Regulation for Tumor Therapy.Adv Sci (Weinh)2024https://conductscience.org/library/papers/38063781PubMed

Download CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36958586

GET https://conductscience.org/api/papers/v1/36958586/references?page=2